These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 20207504)

  • 1. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.
    Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
    Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy.
    Shoushtari A; Saylor D; Kerr KL; Sheng K; Thomas C; Jameson M; Reibel J; Shonka D; Levine P; Read P
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e83-91. PubMed ID: 21377283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].
    Klop WM; Balm AJ; Keus RB; Hilgers FJ; Tan IB
    Ned Tijdschr Geneeskd; 2000 Jul; 144(28):1355-60. PubMed ID: 10923158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer.
    Madani I; Vakaet L; Bonte K; Boterberg T; De Neve W
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1158-66. PubMed ID: 18258383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.
    Ligey A; Gentil J; Créhange G; Montbarbon X; Pommier P; Peignaux K; Truc G; Maingon P
    Radiother Oncol; 2009 Dec; 93(3):483-7. PubMed ID: 19892420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection?
    Aslani M; Sultanem K; Voung T; Hier M; Niazi T; Shenouda G
    Head Neck; 2007 Jun; 29(6):585-90. PubMed ID: 17274051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
    Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical lymph node metastases from occult squamous cell carcinoma: analysis of 82 cases.
    Boscolo-Rizzo P; Da Mosto MC; Gava A; Marchiori C
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(4):189-94. PubMed ID: 16479145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neck lymph node metastases from an unknown primary tumor retrospective study and review of literature.
    Christiansen H; Hermann RM; Martin A; Nitsche M; Schmidberger H; Pradier O
    Strahlenther Onkol; 2005 Jun; 181(6):355-62. PubMed ID: 15925977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
    Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
    Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
    Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective neck dissection for node-positive necks in patients with head and neck squamous cell carcinoma: a word of caution.
    Santos AB; Cernea CR; Inoue M; Ferraz AR
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):79-81. PubMed ID: 16415434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?
    Yao M; Hoffman HT; Chang K; Funk GF; Smith RB; Tan H; Clamon GH; Dornfeld K; Buatti JM
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):707-13. PubMed ID: 17379453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma from an unknown head and neck primary site: a "selective treatment" approach.
    Patel RS; Clark J; Wyten R; Gao K; O'Brien CJ
    Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1282-7. PubMed ID: 18086973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.